These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38192032)

  • 1. Expression and function of the urea cycle in widely-used hepatic cellular models.
    Makris G; Veit L; Rüfenacht V; Klassa S; Zürcher N; Matsumoto S; Poms M; Häberle J
    J Inherit Metab Dis; 2024 Jan; ():. PubMed ID: 38192032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporin 9 induction in human iPSC-derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency.
    Laemmle A; Poms M; Hsu B; Borsuk M; Rüfenacht V; Robinson J; Sadowski MC; Nuoffer JM; Häberle J; Willenbring H
    Hepatology; 2022 Sep; 76(3):646-659. PubMed ID: 34786702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines.
    Gao X; Liu Y
    Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency.
    McGuire PJ; Tarasenko TN; Wang T; Levy E; Zerfas PM; Moran T; Lee HS; Bequette BJ; Diaz GA
    Dis Model Mech; 2014 Feb; 7(2):205-13. PubMed ID: 24271778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
    Mavri-Damelin D; Eaton S; Damelin LH; Rees M; Hodgson HJ; Selden C
    Int J Biochem Cell Biol; 2007; 39(3):555-64. PubMed ID: 17098461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of carbamoyl-phosphate synthase 1 significantly improves ureagenesis of human liver HepaRG cells only when cultured under shaking conditions.
    Adam AAA; van der Mark VA; Ruiter JPN; Wanders RJA; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    Mitochondrion; 2019 Jul; 47():298-308. PubMed ID: 30802674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in methods for characterization of hepatic urea cycle enzymatic activity in HepaRG cells using UPLC-MS/MS.
    Moedas MF; Adam AAA; Farelo MA; IJlst L; Chamuleau RAFM; Hoekstra R; Wanders RJA; Silva MFB
    Anal Biochem; 2017 Oct; 535():47-55. PubMed ID: 28757091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
    Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Inomata Y; Kasahara M; Sakamoto S; Horikawa R; Tanemura A; Okajima H; Suzuki T; Nakamura K
    J Inherit Metab Dis; 2021 Nov; 44(6):1311-1322. PubMed ID: 34232532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1860-8. PubMed ID: 23770120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
    Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
    BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive characterization of ureagenesis in the spf
    Allegri G; Deplazes S; Rimann N; Causton B; Scherer T; Leff JW; Diez-Fernandez C; Klimovskaia A; Fingerhut R; Krijt J; Kožich V; Nuoffer JM; Grisch-Chan HM; Thöny B; Häberle J
    J Inherit Metab Dis; 2019 Nov; 42(6):1064-1076. PubMed ID: 30714172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liver.
    Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
    Liver Int; 2013 Apr; 33(4):516-24. PubMed ID: 23387413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urea cycle disorders-update.
    Matsumoto S; Häberle J; Kido J; Mitsubuchi H; Endo F; Nakamura K
    J Hum Genet; 2019 Sep; 64(9):833-847. PubMed ID: 31110235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects.
    Meyburg J; Hoffmann GF
    Mol Genet Metab; 2010; 100 Suppl 1():S77-83. PubMed ID: 20156696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders.
    Posset R; Gropman AL; Nagamani SCS; Burrage LC; Bedoyan JK; Wong D; Berry GT; Baumgartner MR; Yudkoff M; Zielonka M; Hoffmann GF; Burgard P; Schulze A; McCandless SE; Garcia-Cazorla A; Seminara J; Garbade SF; Kölker S;
    Ann Neurol; 2019 Jul; 86(1):116-128. PubMed ID: 31018246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
    J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency.
    Belanger AJ; Gefteas E; Przybylska M; Geller S; Anarat-Cappillino G; Kloss A; Yew NS
    J Inherit Metab Dis; 2023 Jan; 46(1):55-65. PubMed ID: 36220785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
    Scaglia F; Carter S; O'Brien WE; Lee B
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.